Ambey Laboratories Balance Sheet Health
Financial Health criteria checks 4/6
Ambey Laboratories has a total shareholder equity of ₹745.3M and total debt of ₹279.9M, which brings its debt-to-equity ratio to 37.6%. Its total assets and total liabilities are ₹1.3B and ₹602.0M respectively. Ambey Laboratories's EBIT is ₹95.6M making its interest coverage ratio 3.1. It has cash and short-term investments of ₹49.5M.
Key information
37.6%
Debt to equity ratio
₹279.92m
Debt
| Interest coverage ratio | 3.1x |
| Cash | ₹49.52m |
| Equity | ₹745.33m |
| Total liabilities | ₹602.04m |
| Total assets | ₹1.35b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AMBEY's short term assets (₹963.9M) exceed its short term liabilities (₹457.0M).
Long Term Liabilities: AMBEY's short term assets (₹963.9M) exceed its long term liabilities (₹145.0M).
Debt to Equity History and Analysis
Debt Level: AMBEY's net debt to equity ratio (30.9%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if AMBEY's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: AMBEY's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: AMBEY's interest payments on its debt are well covered by EBIT (3.1x coverage).